FIBA Technologies, Inc. has stepped up production of its vaporisers to meet demands from hospitals across the US and beyond.

FIBA’s products range up to 20,000 standard cubic feet per hour (SCFH) and are available for immediate delivery, according to the Littleton, Massachusetts-based company.

Oxygen has been in an increased demand to treat coronavirus (Covid-19) patients since outbreak of the pandemic in March last year, and vaporisers – where liquid oxygen turns into gas at hospital sites – are an important part of the infrastructure.

FIBA sales director, Chris Finn, said the response from across the gas sector has been very positive.

“Our customers are fully supportive of us temporarily refocusing our resources on meeting the urgent need for more vaporisers in medical units across the US and more widely,” Finn said.

“We began reprioritising manufacturing at our Kentucky and Ohio sites ahead of the anticipated increase in demand so we’re now building to stock in order to have immediate availability for urgent use. Hospitals are the priority for us at the moment and we’re re-doubling efforts to have vaporisers available to ship where they are needed as soon as they are needed.”